Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Raxone®/Catena® (idebenone)
Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
New Drugs Online report for idebenone
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Thrombotic microangiopathy associated with use of interferon-beta.
Translating Fatigue to Human Performance.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Zebrafish myelination: a transparent model for remyelination?

Pages